Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%87 EV-to-FCF is 16.22 as of Sep. 06, 2026, which is 7% below its 10-year median of 17.52. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 71 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 50.7% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Soho Global Health Tbk's Enterprise Value is Rp14,577,404 Mil.
PT Soho Global Health Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was Rp898,470 Mil. Therefore, PT Soho Global Health Tbk's EV-to-FCF for today is 16.22.
The historical rank and industry rank for PT Soho Global Health Tbk's EV-to-FCF or its related term are showing as below:
ISX:SOHO'
s EV-to-FCF Range Over the Past 10 Years
Min: -831.3 Med: 17.52 Max: 63.1
Current: 16.22
During the past 7 years, the highest EV-to-FCF of PT Soho Global Health Tbk was 63.10. The lowest was -831.30. And the median was 17.52.
ISX:SOHO's EV-to-FCF is ranked better than 50.7% of 71
companies
in the Medical Distribution industry
Industry Median: 17.8
vs ISX:SOHO: 16.22
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Soho Global Health Tbk (ISX:SOHO) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Soho Global Health Tbk's PE Ratio (TTM) for today is calculated as:
PT Soho Global Health Tbk's share price for today is Rp1205.00.
PT Soho Global Health Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp53.178.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Soho Global Health Tbk EV-to-FCF Related Terms
PT Soho Global Health Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Soho Global Health Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's EV-to-FCF falls into.
PT Soho Global Health Tbk's current Enterprise Value is Rp14,577,404 Mil.
PT Soho Global Health Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp898,470 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk (ISX:SOHO) has a EV-to-FCF of 16.22 as of Sep. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Soho Global Health Tbk and its competitors. This is near median its historical median of 17.52. According to the industry distribution chart, PT Soho Global Health Tbk ranks #35 out of 71 companies in the Medical Distribution industry, placing it in the top 49.3%.
Is PT Soho Global Health Tbk's EV-to-FCF too high?
PT Soho Global Health Tbk's current EV-to-FCF of 16.22 is near median its 10-year median of 17.52. The Medical Distribution industry median EV-to-FCF is 17.80. PT Soho Global Health Tbk's value of 16.22 is 8.9% below this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #35 out of 71 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #35 out of 71 companies for EV-to-FCF. This puts PT Soho Global Health Tbk in the upper half of its industry. The industry median EV-to-FCF is 17.80. PT Soho Global Health Tbk's value of 16.22 is 8.9% below this benchmark. While the company's 10-year median is 17.52 vs. the industry median of 17.80, PT Soho Global Health Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.80, based on 71 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current EV-to-FCF of 16.22 is 8.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current EV-to-FCF is 16.22, which is near median its own 10-year median of 17.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current EV-to-FCF is 16.22, which is near median its 10-year median of 17.52 and 8.9% below the Medical Distribution industry median of 17.80. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current EV-to-FCF is 16.22 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
EV-to-FCF: 16.22 (near median its 10-year median of 17.52)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 8.9% below the Medical Distribution median (#35 of 71)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score
Get the complete analysis for ISX:SOHO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
